|
Grants
Awarded
Anti-Smallpox
Therapeutics from Marine Microorganisms
National Center
for Complementary & Alternative Medicine
Development
of Novel Anti-Influenza Agents
National Institute
of Allergy and Infectious Diseases
Development
of a Natural Cannabinoid Product
National Cancer
Institute
SuperFluidsTM
Isolation
of Natural Anti-Cancer Products, Fast Track Phases I and II
National Cancer
Institute
Development
of a Marine Anti-Plaque Compound, Phase I
National Institute
of Dental and Cranofacial Research
Standardized
and Improved Saw Palmetto Product
National Center
for Complementary & Alternative Medicine
Virus
Inactivation Device for Medical Devices
Food and Drug Administration
Development
of a Controlled Release HIV Vaccine Adjuvant
National Institute
of Allergy and Infectious Disease
Development
of an Improved Virus-free Fibrin Glue
National Institute
of General Medical Science
Method
for Making an Improved St. John's Wort Product, Fast Track
Phase I & I I
National
Center for Alternative Medicine
Solvent-Free
Protein Comminution, Phase I
National
Institute of General Medical Science
Electric
Field Virus Inactivation, Phase I
National
Heart, Lung and Blood Institute
Development
of a HIV Therapeutic Vaccine, Phase I
National
Institute of Allergy and Infectious Diseases
Novel
Bioadhesive Microspheres, Phase I
National
Institute of General Medical Science
Crystallization
of Natural Therapeutics, Phase I
National
Cancer Institute
Topical
Treatment of Kaposi's Sarcoma, Phase I
National
Cancer Institute
Virus
Inactivation in an Electric Field, Phase I
National
Science Foundation
Novel
Anti-HIV Chemotypes from Marine Microorganisms
National Institute of Allergy and Infectious Diseases
SuperFluidsTM
CXP of
Bryostatin 1, Phase II
National Cancer Institute
SuperFluidsTM
CXP of
Pyrotechnics, Phase I
Department
of Defense
SuperFluidsTM
CFI
of
Fibrin Glue, Phase I
National
Institute of General Medical Science
Improved
Drug Formulation, Phase II
National
Science Foundation
Crystallization
of Natural Products, Phase I
National
Science Foundation
Marine
Microorganisms and Saline Fermentation, ATP
National
Institute of Standards and Technology
Reversed
Micellar Fractionation of Recombinant Proteins, Phase II
National Science Foundation
Fluorophore
Labeled Nucleic Acid Probes for Oncogenes
National Cancer Institute
SuperFluidsTM
CXP
of Michellamine B, Phase I
National Cancer
Institute
Improved
Isolation of Bryostatin 1, Phase I
National
Cancer Institute
Biphasic
Aqueous Fractionation of Lymphokines, Phase I
National
Institutes of Health
Reversed
Micellar Fractionation of Recombinant Proteins, Phase I
National
Science Foundation
Low
Temperature Viral Inactivation, ATP
National Institute of Standards and Technology
Liposome
Encapsulation of Taxol, Phase I
National
Cancer Institute
Extraction
and Purification of Taxol, Phase II
National
Cancer Institute
Extraction
and Purification of Taxol, Phase I
National
Cancer Institute
Improved
Biomass Defibration
Department
of Agriculture
Improved
Drug Formulation, Phase I
National Science Foundation
Microbial
Cell Disruption, Phase II
National Science Foundation
Microbial
Cell Disruption, Phase I
National Science Foundation
Home
l Company | Infectious
Diseases | Oncology | Nutraceuticals
| Product Pipeline | Purchase
Products | Technology Platforms
| Equipment |Patents
| Press
Releases | Contact Aphios
©1999-
2007 Aphios® Corporation
All rights reserved
|
